Positive Results for Patisiran in ATTR Amyloidosis Cardiomyopathy ...Middle East

Medscape - News
The RNAi therapeutic patisiran improves functional capacity and quality of life in ATTR amyloidosis with cardiomyopathy, topline results of APOLLO-B show. The company will seek an FDA supplemental NDA. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results for Patisiran in ATTR Amyloidosis Cardiomyopathy )

Apple Storegoogle play

Also on site :